经皮冠状动脉介入治疗患者的高敏 C 反应蛋白与高密度脂蛋白胆固醇比值与对比度诱发急性肾损伤的风险。

IF 1.9 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS
Reviews in cardiovascular medicine Pub Date : 2024-09-23 eCollection Date: 2024-09-01 DOI:10.31083/j.rcm2509338
Linxiao Deng, Hua Chen, Qingbo Xu, Kedong Han, Jin Liu, Shiqun Chen, Jingru Deng, Leigang Tian, Zeliang Li, Xiaozhao Lu, Yong Liu, Yan Liang
{"title":"经皮冠状动脉介入治疗患者的高敏 C 反应蛋白与高密度脂蛋白胆固醇比值与对比度诱发急性肾损伤的风险。","authors":"Linxiao Deng, Hua Chen, Qingbo Xu, Kedong Han, Jin Liu, Shiqun Chen, Jingru Deng, Leigang Tian, Zeliang Li, Xiaozhao Lu, Yong Liu, Yan Liang","doi":"10.31083/j.rcm2509338","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The high-sensitivity C-reactive protein to high-density lipoprotein cholesterol ratio (CHR) is a novel biomarker associated with coronary artery disease (CAD) risk. This study aimed to analyze the relationship between CHR and contrast-induced acute kidney injury (CI-AKI).</p><p><strong>Methods: </strong>This retrospective cross-sectional research included 10,917 individuals who underwent PCI. CI-AKI was diagnosed using the Kidney Disease: Improving Global Outcomes (KIDIGO) standard. Univariate and multivariable logistic regression analyses were conducted to examine the association between CHR and CI-AKI, followed by a receiver operating characteristic (ROC) curve of participants to assess the clinical diagnostic performance of CHR on CI-AKI.</p><p><strong>Results: </strong>A total of 1037 patients (9.50%) developed CI-AKI after PCI. The age of individuals averaged 64.1 ± 11.1 years old, with 2511 females (23.0%). A multivariate logistic regression study revealed that higher CHR levels were linked to higher CI-AKI incidence rates ([Q4 vs. Q1]: odds ratio (OR) = 1.89, 95% confidence interval (CI) [1.42 to 2.54], <i>p</i> < 0.001). A restricted cubic spline analysis revealed a linear association between CHR and CI-AKI. ROC analysis indicated that CHR was an excellent predictor of CI-AKI (area under ROC curve = 0.606, 95% CI [0.588 to 0.624]).</p><p><strong>Conclusions: </strong>A high CHR level is strongly associated with increased CI-AKI incidence, suggesting that CHR may be an independent risk factor for CI-AKI.</p><p><strong>Clinical trial registration: </strong>NCT05050877. https://clinicaltrials.gov/study/NCT05050877?tab=results.</p>","PeriodicalId":20989,"journal":{"name":"Reviews in cardiovascular medicine","volume":"25 9","pages":"338"},"PeriodicalIF":1.9000,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11440391/pdf/","citationCount":"0","resultStr":"{\"title\":\"The High-Sensitivity C-Reactive Protein to High-Density Lipoprotein Cholesterol Ratio and the Risk of Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention.\",\"authors\":\"Linxiao Deng, Hua Chen, Qingbo Xu, Kedong Han, Jin Liu, Shiqun Chen, Jingru Deng, Leigang Tian, Zeliang Li, Xiaozhao Lu, Yong Liu, Yan Liang\",\"doi\":\"10.31083/j.rcm2509338\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The high-sensitivity C-reactive protein to high-density lipoprotein cholesterol ratio (CHR) is a novel biomarker associated with coronary artery disease (CAD) risk. This study aimed to analyze the relationship between CHR and contrast-induced acute kidney injury (CI-AKI).</p><p><strong>Methods: </strong>This retrospective cross-sectional research included 10,917 individuals who underwent PCI. CI-AKI was diagnosed using the Kidney Disease: Improving Global Outcomes (KIDIGO) standard. Univariate and multivariable logistic regression analyses were conducted to examine the association between CHR and CI-AKI, followed by a receiver operating characteristic (ROC) curve of participants to assess the clinical diagnostic performance of CHR on CI-AKI.</p><p><strong>Results: </strong>A total of 1037 patients (9.50%) developed CI-AKI after PCI. The age of individuals averaged 64.1 ± 11.1 years old, with 2511 females (23.0%). A multivariate logistic regression study revealed that higher CHR levels were linked to higher CI-AKI incidence rates ([Q4 vs. Q1]: odds ratio (OR) = 1.89, 95% confidence interval (CI) [1.42 to 2.54], <i>p</i> < 0.001). A restricted cubic spline analysis revealed a linear association between CHR and CI-AKI. ROC analysis indicated that CHR was an excellent predictor of CI-AKI (area under ROC curve = 0.606, 95% CI [0.588 to 0.624]).</p><p><strong>Conclusions: </strong>A high CHR level is strongly associated with increased CI-AKI incidence, suggesting that CHR may be an independent risk factor for CI-AKI.</p><p><strong>Clinical trial registration: </strong>NCT05050877. https://clinicaltrials.gov/study/NCT05050877?tab=results.</p>\",\"PeriodicalId\":20989,\"journal\":{\"name\":\"Reviews in cardiovascular medicine\",\"volume\":\"25 9\",\"pages\":\"338\"},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2024-09-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11440391/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Reviews in cardiovascular medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.31083/j.rcm2509338\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/9/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reviews in cardiovascular medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.31083/j.rcm2509338","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

背景:高敏C反应蛋白与高密度脂蛋白胆固醇比值(CHR)是与冠状动脉疾病(CAD)风险相关的新型生物标志物。本研究旨在分析 CHR 与造影剂诱发的急性肾损伤(CI-AKI)之间的关系:这项回顾性横断面研究纳入了 10,917 名接受 PCI 的患者。CI-AKI通过肾脏疾病:改善全球预后(KIDIGO)标准进行诊断。研究人员进行了单变量和多变量逻辑回归分析,以检验CHR与CI-AKI之间的关联,随后对参与者进行了接收器操作特征(ROC)曲线分析,以评估CHR对CI-AKI的临床诊断性能:共有1037名患者(9.50%)在PCI术后发生了CI-AKI。患者平均年龄为(64.1 ± 11.1)岁,其中女性 2511 人(23.0%)。多变量逻辑回归研究显示,CHR水平越高,CI-AKI发病率越高([Q4 vs. Q1]:几率比(OR)= 1.89,95% 置信区间(CI)[1.42 至 2.54],P < 0.001)。限制性三次样条分析显示,CHR 与 CI-AKI 之间存在线性关系。ROC分析表明,CHR能很好地预测CI-AKI(ROC曲线下面积=0.606,95% CI [0.588至0.624]):结论:高CHR水平与CI-AKI发生率增加密切相关,表明CHR可能是CI-AKI的独立危险因素:临床试验注册:NCT05050877。https://clinicaltrials.gov/study/NCT05050877?tab=results。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The High-Sensitivity C-Reactive Protein to High-Density Lipoprotein Cholesterol Ratio and the Risk of Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention.

Background: The high-sensitivity C-reactive protein to high-density lipoprotein cholesterol ratio (CHR) is a novel biomarker associated with coronary artery disease (CAD) risk. This study aimed to analyze the relationship between CHR and contrast-induced acute kidney injury (CI-AKI).

Methods: This retrospective cross-sectional research included 10,917 individuals who underwent PCI. CI-AKI was diagnosed using the Kidney Disease: Improving Global Outcomes (KIDIGO) standard. Univariate and multivariable logistic regression analyses were conducted to examine the association between CHR and CI-AKI, followed by a receiver operating characteristic (ROC) curve of participants to assess the clinical diagnostic performance of CHR on CI-AKI.

Results: A total of 1037 patients (9.50%) developed CI-AKI after PCI. The age of individuals averaged 64.1 ± 11.1 years old, with 2511 females (23.0%). A multivariate logistic regression study revealed that higher CHR levels were linked to higher CI-AKI incidence rates ([Q4 vs. Q1]: odds ratio (OR) = 1.89, 95% confidence interval (CI) [1.42 to 2.54], p < 0.001). A restricted cubic spline analysis revealed a linear association between CHR and CI-AKI. ROC analysis indicated that CHR was an excellent predictor of CI-AKI (area under ROC curve = 0.606, 95% CI [0.588 to 0.624]).

Conclusions: A high CHR level is strongly associated with increased CI-AKI incidence, suggesting that CHR may be an independent risk factor for CI-AKI.

Clinical trial registration: NCT05050877. https://clinicaltrials.gov/study/NCT05050877?tab=results.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Reviews in cardiovascular medicine
Reviews in cardiovascular medicine 医学-心血管系统
CiteScore
2.70
自引率
3.70%
发文量
377
审稿时长
1 months
期刊介绍: RCM is an international, peer-reviewed, open access journal. RCM publishes research articles, review papers and short communications on cardiovascular medicine as well as research on cardiovascular disease. We aim to provide a forum for publishing papers which explore the pathogenesis and promote the progression of cardiac and vascular diseases. We also seek to establish an interdisciplinary platform, focusing on translational issues, to facilitate the advancement of research, clinical treatment and diagnostic procedures. Heart surgery, cardiovascular imaging, risk factors and various clinical cardiac & vascular research will be considered.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信